References
Brass A L, Dykxhoorn D M, Benita Y, Yan N, Engelman A, Xavier R J, Lieberman J, Elledge S J. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science, 319: 921–926.
Das A T, Baldwin C E, Vink M, Berkhout B. 2005. Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry. J Virol, 79: 3855–3858.
Das A T, Klaver B, Harwig A, Vink M, Ooms M, Centlivre M, Berkhout B. 2007. Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replicationh. J Virol, 81: 11159–11169.
Garrus J E, von Schwedler U K, Pornillos O W, Morham S G, Zavitz K H, Wang H E, Wettstein D A, Stray K M, Côté M, Rich R L, Myszka D G, Sundquist W I. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell, 107: 55–65.
Hosseinipour M C, Gupta R K, Van Zyl G, Eron J J, Nachega J B. 2013. Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings. J Infect Dis, 207Suppl 2: S49–56.
Katlama C, Deeks S G, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, Miller M, Vella S, Schmitz J E, Ahlers J, Richman D D, Sekaly R P. 2013. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet, 381: 2109–2117.
Platt E J, Bilska M, Kozak S L, Kabat D, Montefiori D C. 2009. Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1. J Viro, 83: 8289–8292.
Sadaie M R, Benter T, Wong-Staal F. 1988. Site-directed mutagenesis of two trans-regulatory genes (tat-III, trs) of HIV-1. Science, 239: 910–913.
Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E. 2013. Reactivation of latent HIV by histone deacetylase inhibitors. Trends Microbiol, 21: 277–285.
Walker B D, Yu X G. 2013. Unravelling the mechanisms of durable control of HIV-1. Nat Rev Immunol, 13: 487–498.
Wei P, Garber M E, Fang S M, Fischer W H, Jones K A. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell, 92: 451–462.
Zhang J X, Diehl G E, Littman D R. 2008. Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells. PLoS One,3: e2035.
Zhou H, Xu M, Huang Q, Gates A T, Zhang X D, Castle J C, Stec E, Ferrer M, Strulovici B, Hazuda D J, Espeseth A S. 2008. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe, 4: 495–504.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hu, Y., Zhang, J. Screening strategies to identify host factors associated with the early and late stages of HIV-1 life cycle. Virol. Sin. 28, 242–245 (2013). https://doi.org/10.1007/s12250-013-3359-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-013-3359-9